Eucalyptus oil is one of the most widely used essential oils in the world, and one of the four “classical” ingredients found in almost every Hong Kong and Southeast Asian medicated oil formulation — alongside menthol, camphor, and methyl salicylate. Where those three dominate the sensory and analgesic profile, eucalyptus quietly adds the respiratory dimension: the “open airways” feeling when you inhale Tiger Balm White at 35,000 feet, the mild decongestant edge in Po Sum On, the crisp top note in White Flower Embrocation, and the subtle aromatic depth behind Wong To Yick’s salicylate-heavy bite.
This article walks through what eucalyptus oil actually is, the pharmacology of its main active compound 1,8-cineole (eucalyptol), what mechanisms explain its mucolytic, expectorant, and anti-inflammatory effects, how it interacts with cold-receptor TRPM8 and irritant-receptor TRPA1, and what the real safety profile looks like — particularly for children, pregnant women, and people with asthma. It also maps the concentration of eucalyptus and cineole across the major Hong Kong medicated oils so you can understand exactly what role it plays in each.
Eucalyptus oil is a volatile essential oil steam-distilled from the leaves and terminal branches of various species of the Eucalyptus genus, most commonly Eucalyptus globulus (Tasmanian blue gum), Eucalyptus radiata (narrow-leaved peppermint), and Eucalyptus polybractea (blue mallee). The genus is native to Australia, where more than 700 species grow, but commercial production today also comes from China, Portugal, South Africa, Brazil, and Spain. China is the world’s largest producer by volume, supplying most of the eucalyptus oil used in Asian medicated-oil manufacturing.
The oil is a clear to pale yellow liquid with a characteristic fresh, camphoraceous, slightly sweet aroma. Its main active compound, 1,8-cineole, typically makes up 65–90% of pharmaceutical-grade eucalyptus oil — and it is 1,8-cineole content that defines “BP grade” or “Eucalyptus Oil BP” used in medicated oils. Products marked “Eucalyptus Oil BP” must contain a minimum of 70% 1,8-cineole per British Pharmacopoeia standards.
The remaining 10–35% is a mix of α-pinene, β-pinene, limonene, p-cymene, α-terpineol, aromadendrene, and small amounts of other monoterpenes and sesquiterpenes. These minor constituents contribute aromatic complexity and modest biological activity but the overwhelming majority of the therapeutic effect is attributed to 1,8-cineole.
1,8-Cineole (also called eucalyptol) is a bicyclic ether with molecular formula C10H18O. It is a colourless, mobile liquid with a fresh, camphor-like, slightly sweet odour and a cooling, spicy taste. Beyond eucalyptus, it is also the major component of cajuput oil (60–75%), niaouli oil (40–55%), rosemary oil (~50%), bay laurel oil (~45%), and is found in smaller amounts in sage, tea tree, and ginger.
1,8-Cineole is one of the best-studied monoterpene ethers in respiratory medicine, with decades of clinical trials supporting its use in bronchitis, sinusitis, rhinosinusitis, and chronic obstructive pulmonary disease (COPD). In Germany it is registered as a standalone pharmaceutical product under the trade name Soledum (cineole 100mg capsules), prescribed for bronchitis and sinusitis, and it is on the WHO list of traditional medicine actives.
When eucalyptus oil is applied topically in medicated-oil form, 1,8-cineole is absorbed through two main routes:
Transdermal: Through intact skin, reaching systemic circulation within 15–30 minutes. Peak plasma concentrations are reached within 1–2 hours and half-life is approximately 1.5 hours.
Inhalation: Volatile 1,8-cineole vapour is absorbed rapidly through the upper respiratory mucosa and lungs, reaching the bloodstream within minutes. This is the primary route when a medicated oil is dabbed under the nose, rubbed on the chest, or applied near the face.
Once absorbed, 1,8-cineole is metabolised mainly in the liver by cytochrome P450 enzymes (CYP3A4 and CYP2C19) to hydroxy-cineole metabolites, which are then conjugated and excreted in urine. A small fraction is exhaled unchanged through the lungs — which is part of why inhaled cineole “comes back out” through the airways, extending the local mucolytic effect.
1,8-cineole has at least four distinct mechanisms that contribute to its therapeutic effects in medicated-oil formulations:
1,8-cineole reduces the viscosity of airway mucus by stimulating mucosal glands and altering the structure of mucin glycoproteins. In clinical studies of bronchitis patients, oral cineole 200mg three times daily produced measurable improvements in mucus clearance, forced expiratory volume (FEV1), and symptom scores within 4–7 days. The mechanism is thought to involve increased production of thinner serous fluid in bronchial glands, combined with stimulation of ciliary beat frequency in the tracheobronchial mucosa.
In medicated-oil form — particularly rubbed on the chest or inhaled — this translates into the “opening” feeling in the airways and the easier coughing-up of mucus that makes eucalyptus-containing balms a traditional remedy for mild cold and flu symptoms.
1,8-cineole inhibits production of several pro-inflammatory mediators including:
The main molecular target is the NF-κB pathway, which 1,8-cineole inhibits in a dose-dependent manner in vitro. This is clinically meaningful in airway inflammation, where NF-κB-driven cytokine release is the core driver of the “stuffy, congested” feeling in sinusitis and bronchitis.
1,8-cineole has measurable activity against a range of respiratory pathogens:
In the context of medicated oils, the antimicrobial activity is not strong enough to treat an established infection — but it contributes to the “fresh” feeling and may offer some supportive effect in mild upper respiratory irritation.
Like menthol, 1,8-cineole activates TRPM8, the cold-sensing TRP channel on sensory neurons — though with much lower potency than menthol itself. This explains the mild “cool” component of the eucalyptus sensation. At higher concentrations cineole also weakly activates TRPA1, the irritant/pungency receptor, which contributes to the “sharp” or “biting” note in stronger formulations.
This dual receptor activity means eucalyptus has a sensory profile that sits between menthol (pure cool, TRPM8) and mustard oil or cinnamon (pure irritant, TRPA1), giving it the characteristic “fresh but not quite cold” feeling that you notice in Tiger Balm White and White Flower Embrocation.
The eucalyptus oil content of the major brands is approximate (most manufacturers don’t list exact percentages) but can be estimated from labelled content and product smell:
| Product | Eucalyptus oil % | 1,8-cineole equivalent | Role |
|---|---|---|---|
| Tiger Balm White | ~13–15% | ~10–12% | Major — respiratory + cool top note |
| White Flower Embrocation | ~6% | ~4–5% | Supporting — aromatic |
| Po Sum On | ~3–5% | ~2–4% | Supporting — mild decongestant |
| Wong To Yick Wood Lock | ~2–3% | ~1.5–2% | Minor — aromatic background |
| Tiger Balm Red | ~1–3% | ~1–2% | Minor — aromatic background |
| Vicks VapoRub | ~1.2% | ~1% | Labelled — respiratory support |
| Axe Brand Universal Oil | ~7% | ~5–6% | Moderate — respiratory + aromatic |
Tiger Balm White is the most eucalyptus-forward formulation in the Hong Kong medicated oil category, which is why it is traditionally used for headaches, sinus congestion, and light cold symptoms rather than deep muscle pain. The pairing of cajuput oil (also cineole-rich, ~55% cineole) with eucalyptus oil in Tiger Balm White gives it one of the highest total cineole contents of any commercial balm.
Eucalyptus oil is generally well-tolerated at the concentrations found in medicated oils, but it is not risk-free. The main safety concerns are:
Contraindicated. Topical application of eucalyptus oil or cineole-containing products to the face, nose, or chest of infants and young children has been reported to cause laryngospasm, bronchospasm, and respiratory arrest. This is the same mechanism that makes menthol and camphor dangerous in young children — the developing respiratory tract is highly sensitive to volatile terpenes.
All major medicated oils containing eucalyptus carry the “do not apply to infants and children under 2” warning, and this should be taken seriously. A dab of Tiger Balm White on a one-year-old’s chest can trigger a life-threatening breathing event.
For children aged 2–6, use only very small amounts, never on the face or directly under the nose, and never inside the nostrils. For children 6+, the adult precautions apply but with smaller doses.
Swallowing concentrated eucalyptus oil is seriously dangerous. As little as 3.5 mL of pure eucalyptus oil has caused fatal poisoning in children, and larger doses in adults have caused seizures, coma, and death. The toxic dose is around 0.05–0.5 mL/kg. Medicated oil bottles should be kept out of reach of children and in childproof packaging where possible.
Symptoms of eucalyptus oil poisoning include:
If ingestion occurs, contact poison control immediately. Do not induce vomiting — this can cause aspiration pneumonitis, which is actually the main cause of death in eucalyptus oil poisoning.
Eucalyptus oil has a paradoxical relationship with asthma. In some patients, inhaled 1,8-cineole is actually bronchodilator and anti-inflammatory — clinical trials of oral cineole in moderate-to-severe asthma have shown improvement in FEV1 and symptom scores. But in other patients, especially those with aspirin-sensitive asthma or reactive airways, eucalyptus can trigger bronchospasm.
The practical rule: if you have asthma and have never used eucalyptus-containing products, start with a tiny amount on a small area and observe for 30 minutes. If any wheezing or chest tightness develops, discontinue immediately. Do not use eucalyptus-based products during an active asthma exacerbation.
Eucalyptus oil is classed as “use with caution in pregnancy” — there is no high-quality evidence of teratogenicity at topical medicated-oil doses, but 1,8-cineole crosses the placenta and has theoretical effects on uterine smooth muscle. Most Hong Kong TCM practitioners advise pregnant women to avoid eucalyptus-containing balms, particularly in the first trimester. If use is unavoidable (e.g., for a bad headache), restrict to a tiny dab on the temples and do not apply to the abdomen.
See our Medicated Oils During Pregnancy article for the full pregnancy protocol.
1,8-Cineole has not been specifically linked to G6PD-triggered haemolysis (unlike menthol, which has case reports). However, the standard advice is to err on the side of caution and restrict use to small areas in G6PD patients. See our G6PD Deficiency article for details.
1,8-Cineole is a moderate inducer of CYP3A4 in rodents and humans, which theoretically means it could lower the plasma levels of drugs metabolised by CYP3A4 (many statins, calcium channel blockers, immunosuppressants, some antidepressants). At typical topical medicated-oil doses this is almost certainly not clinically significant — but people on narrow-therapeutic-index CYP3A4 substrates (tacrolimus, cyclosporine) should consult their physician.
Contact dermatitis to eucalyptus oil is uncommon but does occur. The main culprits are usually oxidised 1,8-cineole (old or poorly stored oil develops allergenic oxidation products) and the minor monoterpenes like α-pinene. If redness, itching, or rash develop after applying a eucalyptus-containing balm, discontinue and wash the area with soap and water.
Evidence-based uses for eucalyptus oil at medicated-oil concentrations:
Evidence-based uses for higher-dose oral cineole (Soledum 200–600 mg/day) — not for topical use:
The topical medicated-oil doses of eucalyptus oil are much lower than the oral clinical trial doses, so the systemic effects are correspondingly smaller. Most of the benefit in medicated-oil use comes from the local aromatic and TRPM8 cooling effect plus the inhaled mucolytic action, not from full systemic pharmacology.
How eucalyptus compares to the other “respiratory” aromatic oils used in medicated-oil manufacturing:
| Oil | Main active | % in Tiger Balm White | Mucolytic | Cool (TRPM8) | Warm (TRPV1) |
|---|---|---|---|---|---|
| Eucalyptus | 1,8-cineole (65–90%) | ~13% | Strong | Mild | None |
| Cajuput | 1,8-cineole (55–65%) | ~13% | Strong | Mild | None |
| Peppermint | Menthol (35–50%) | ~5% | Mild | Very strong | None |
| Camphor | Camphor | ~11% | Mild | Mild | Moderate |
| Wintergreen | Methyl salicylate | 0% (none in TB White) | None | None | None |
Key takeaway: Eucalyptus and cajuput are the two dominant “respiratory” oils — both are cineole-rich and deliver the mucolytic and decongestant action. Peppermint/menthol delivers the cool sensation. Camphor delivers moderate warmth. Wintergreen/methyl salicylate delivers anti-inflammatory action. A good medicated oil formulation balances all five for the target indication.
Eucalyptus oil is the quiet workhorse of Hong Kong medicated oils — never the headline ingredient, but present in every major formulation, and particularly dominant in Tiger Balm White, where its cineole content underwrites the “clear head, clear sinus” feeling that makes it a traveller’s essential. Its pharmacology is well-studied: genuine mucolytic, anti-inflammatory, and mild antimicrobial action driven by 1,8-cineole, with real clinical evidence at higher oral doses and plausible supportive evidence at the topical doses found in medicated oils.
The safety profile is good for adults used correctly, but the “no children under 2, no face of young children” rule is absolute and non-negotiable. Asthmatics should test cautiously. Pregnant women should restrict to small amounts on the temples only. Everyone should avoid accidental ingestion.
Used correctly, a eucalyptus-containing balm like Tiger Balm White is one of the safest, most effective, and cheapest interventions for mild cold and headache symptoms anywhere in the world. It is not a substitute for real medicine when real medicine is needed — but for the thousand small daily complaints where a little aromatic cineole helps, it remains one of the classics for a reason.
This article is part of the Medicated Oil Knowledge Hub, a free educational reference on traditional Chinese and Southeast Asian herbal medicated oils. Information here is for education and is not medical advice. For individual medical questions, consult a pharmacist or physician.